# EDGAR Filing Document

**Accession Number:** 0001640266
**File Stem:** 0001104659-25-116421
**Filing Date:** 2025-11
**Character Count:** 2309
**Document Hash:** 5af453f326d55081a4d0991ba0854c66
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-116421.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001104659-25-116421

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Voyager Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001640266
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 75 HAYDEN AVENUE
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421
- **BUSINESS PHONE:** 857-259-5340

**MAIL ADDRESS:**
- **STREET 1:** 75 HAYDEN AVENUE
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421

**VOYAGER THERAPEUTICS, INC.**

75 Hayden Avenue

Lexington, MA 02421

November 26, 2025

**<u>VIA EDGAR SUBMISSION</u>**

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Voyager Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-291418 Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Voyager Therapeutics, Inc. (the "<u>Registrant</u>") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-291418), so that it may become effective at 4:30 p.m., Eastern time, on December 1, 2025, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **VOYAGER THERAPEUTICS, INC.** | **VOYAGER THERAPEUTICS, INC.** |
| By: | /s/ Nathan Jorgensen |
| Name: | Nathan Jorgensen |
| Title: | Chief Financial Officer |

---

---

| | |
|:---|:---|
| cc: | Scott Townsend |
|  | Senior Vice President of Legal and Chief Corporate Counsel |
|  | *Voyager Therapeutics, Inc.* |
|  | Robin Swartz |
|  | Chief Business Officer and Chief Operating Officer |
|  | *Voyager Therapeutics, Inc.* |
|  | Brian A. Johnson |
|  | C.S. Avery Reaves |
|  | *Wilmer Cutler Pickering Hale and Dorr LLP* |

---